Showing results (661-670 of 701) with videos related to
Sort By:
Pageof 71
The Lancet. Diabetes & Endocrinology|December 2, 2021
Dapagliflozin and new-onset type 2 diabetes in patients with chronic kidney disease or heart failure: pooled analysis of the DAPA-CKD and DAPA-HF trialsPeter Rossing, Silvio E Inzucchi, Priya Vart, et al.Cardiovascular Diabetology|April 9, 2022
Report from the CVOT Summit 2021: new cardiovascular, renal, and glycemic outcomesOliver Schnell, Tadej Battelino, Richard Bergenstal, et al.Diabetes|September 24, 2015
Glucose-Dependent Insulinotropic Polypeptide Stimulates Osteopontin Expression in the Vasculature via Endothelin-1 and CREBLisa M Berglund, Valeriya Lyssenko, Claes Ladenvall, et al.The Journal of Clinical Investigation|January 12, 2023
Reduced methylation correlates with diabetic nephropathy risk in type 1 diabetesIshant Khurana, Harikrishnan Kaipananickal, Scott Maxwell, et al.Diabetes Care|April 4, 2022
Urinary Proteomics Identifies Cathepsin D as a Biomarker of Rapid eGFR Decline in Type 1 DiabetesChristine P Limonte, Erkka Valo, Viktor Drel, et al.Frontiers in Clinical Diabetes and Healthcare|March 30, 2023
Making Use of Comparable Health Data to Improve Quality of Care and Outcomes in Diabetes: The EUBIROD Review of Diabetes Registries and Data Sources in EuropeFabrizio Carinci, Iztok Štotl, Scott G Cunningham, et al.Cardiovascular Diabetology|March 17, 2023
CVOT Summit 2022 Report: new cardiovascular, kidney, and glycemic outcomesOliver Schnell, Tadej Battelino, Richard Bergenstal, et al.European Heart Journal|March 26, 2026
Sex differences in cardiovascular-kidney-metabolic syndrome: the FINE-HEART pooled analysisMaria A Pabon, John W Ostrominski, Xiaowen Wang, et al.Diabetologia|June 10, 2021
Replication and cross-validation of type 2 diabetes subtypes based on clinical variables: an IMI-RHAPSODY studyRoderick C Slieker, Louise A Donnelly, Hugo Fitipaldi, et al.The New England Journal of Medicine|September 23, 2021
New Creatinine- and Cystatin C-Based Equations to Estimate GFR without RaceLesley A Inker, Nwamaka D Eneanya, Josef Coresh, et al.Pageof 71